Adam Daniel Cutler

Adam Daniel Cutler

Net worth: 385 621 $ as of 2024-03-30

50 year
Finance
Health Technology
Commercial Services

Profile

Mr. Adam D.
Cutler is a Chief Financial & Accounting Officer at Mural Oncology Plc.
Mr. Cutler was previously employed as a Chief Financial Officer by Q32 Bio, Inc. (Massachusetts), an Independent Director by Navidea Biopharmaceuticals, Inc., a Chief Financial Officer, Secretary & Treasurer by Molecular Templates, Inc., an Independent Director by InMed Pharmaceuticals, Inc., a Senior Vice President-Corporate Affairs by Arbutus Biopharma Corp., a Managing Director by The Trout Group LLC, a Managing Director by Trout Capital LLC, a Managing Director by Canaccord Genuity, Inc., an Associate Analyst by Banc of America Securities LLC, a Research Analyst by Credit Suisse Securities (USA) LLC (Broker), an Analyst by The Frankel Group Associates LLC, and a Consultant by Ernst & Young LLP.
He also served on the board at JMP Securities LLC.
He received his undergraduate degree from Brandeis University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.47%
2023-12-13 78,859 ( 0.47% ) 385 621 $ 2024-03-30

Adam Daniel Cutler active positions

Former positions of Adam Daniel Cutler

CompaniesPositionEnd
Director of Finance/CFO 2023-09-30
INMED PHARMACEUTICALS INC. Director/Board Member 2022-08-07
MOLECULAR TEMPLATES, INC. Director of Finance/CFO 2021-07-01
NAVIDEA BIOPHARMACEUTICALS, INC. Director/Board Member 2021-05-03
ARBUTUS BIOPHARMA CORPORATION Corporate Officer/Principal 2017-10-31
See the detail of Adam Daniel Cutler's experience

Training of Adam Daniel Cutler

Brandeis University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adam Daniel Cutler's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
NAVIDEA BIOPHARMACEUTICALS, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

INMED PHARMACEUTICALS INC.

Health Technology

MOLECULAR TEMPLATES, INC.

Health Technology

Private companies8

Finance

Finance

Commercial Services

Finance

Finance

Finance

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Adam Daniel Cutler